Skip to main content

Advertisement

SpringerLink
Log in

Rezum: a novel minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A review article

  • Urology - Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are one of the most common morbidities in elderly men, especially in aging societies. Minimally invasive surgical treatments (MISTs) for BPH have gained an increasing interest in the current time. Rezum system is a novel MIST that uses water vapour-based convective thermal therapy to ablate prostatic tissue. According to our evaluation of the existing literature, Rezum offers a meaningful relief of LUTS with a high safety profile without compromising the sexual activity especially to those who are unfit for surgery or to those who do not desire to continue on lifelong pharmacotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

TUNA:

Transurethral needle ablation of the prostate

TUMT:

Transurethral microwave thermotherapy

MRI:

Magnetic resonance imaging

MISTs:

Minimally invasive surgical treatments

BPH:

Benign prostatic hyperplasia

LUTS:

Lower urinary tract symptoms

QoL:

Quality of life

TURP:

Transurethral resection of the prostate

BPHIII:

Benign prostatic hyperplasia impact index

AUA:

American Urological association

EAU:

European association of Urology

EAU:

National institute of care excellence in UK

PVR:

Post-voiding residual urine

IIEF:

International index of erectile dysfunction

References

  1. Oelke M, Kirschner-Hermanns R, Thiruchelvam N, Heesakkers J (2012) Can we identify men who will have complications from benign prostatic obstruction (BPO)?: ICI-RS 2011. Neurourol Urodyn. 31(3):322–326. https://doi.org/10.1002/nau.22222

    Article  PubMed  Google Scholar 

  2. Magistro G, Chapple CR, Elhilali M, Gilling P, McVary KT, Roehrborn CG et al. (2017) Emerging minimally invasive treatment options for male lower urinary tract symptoms[Figure presented]. Eur Urol. 72(6):986–997. https://doi.org/10.1016/j.eururo.2017.07.005

    Article  PubMed  Google Scholar 

  3. Helo S, Holland B, McVary KT (2017) Convective radiofrequency water vapor thermal therapy with rezūm system. Curr Urol Rep. 18(10):1–7

    Article  Google Scholar 

  4. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC et al. (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140

    Article  Google Scholar 

  5. Pathak P, Helo S, McVary KT (2018) What’s new in Rezūm? Eur Urol Focus 4(1):32–35

    Article  Google Scholar 

  6. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND et al. (2016) Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled study. J Sex Med. 13(6):924–933. https://doi.org/10.1016/j.jsxm.2016.03.372

    Article  PubMed  Google Scholar 

  7. Cantrill CH, Zorn KC, Elterman DS, Gonzalez RR (2019) water vapor thermal therapy for obstructive benign prostatic hyperplasia. Can J Urol. 26(1):9787–9793

    PubMed  Google Scholar 

  8. Tanneru K, Jazayeri SB, Alam MU, Kumar J, Bazargani S, Kuntz G et al. (2021) An indirect comparison of newer minimally invasive treatments for benign prostatic hyperplasia: a network meta-analysis model. J Endourol. https://doi.org/10.1089/end.2020.0739

    Article  PubMed  Google Scholar 

  9. Gupta N, Rogers T, Holland B, Helo S, Dynda D, McVary KT (2018) Three-year treatment outcomes of water vapor thermal therapy compared to Doxazosin, finasteride and combination drug therapy in men with benign prostatic hyperplasia: cohort data from the MTOPS Trial. J Urol. 200(2):405–413. https://doi.org/10.1016/j.juro.2018.02.3088

    Article  CAS  PubMed  Google Scholar 

  10. Green Z, Westwood J, Somani BK (2019) What’s new in rezum: a transurethral water vapour therapy for BPH. Curr Urol Rep 20(7):1–7

    Article  CAS  Google Scholar 

  11. Dixon C, Cedano ER, Mynderse L, Larson T. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm® system: evaluation of acute ablative capabilities in the human prostate. Res Reports Urol. 2015; 7: 13. http://www.dovepress.com/transurethral-convective-water-vapor-as-a-treatment-for-lower-urinary--peer-reviewed-article-RRU

  12. Bhowmick P, Coad JE, Bhowmick S, Pryor JL, Larson T, De La Rosette J et al. (2004) In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int J Hyperth 20(4):421–439

    Article  CAS  Google Scholar 

  13. Arezki A, Sadri I, Couture F, Schwartz R, Nguyen D-D, Zakaria AS et al. (2020) Reasons to go for Rezūm steam therapy: an effective and durable outpatient minimally invasive procedure. World J Urol. https://doi.org/10.1007/s00345-020-03457-9

    Article  PubMed  Google Scholar 

  14. McVary KT, Rogers T, Roehrborn CG (2019) Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology 126:171–179. https://doi.org/10.1016/j.urology.2018.12.041

    Article  PubMed  Google Scholar 

  15. Dixon C, Cedeno ER, Pacik D, Varga G, Vit V, Mynderse L (2014) Pd26–09 transurethral water vapor therapy for Bph; 1-year clinical results of the first-in-man and rezūm® I clinical trials using the rezūm® system. J Urol. 191(4):762. https://doi.org/10.1016/j.juro.2014.02.2096

    Article  Google Scholar 

  16. Mynderse L, Hanson D, Robb R, Cedano ER, Pacik D, Varga G et al. (2014) MP71-11 rezūm® system water vapor treatment for benign prostatic hyperplasia: characterization with magnetic resonance imaging and 3D rendering. J Urol. 191(4):794. https://doi.org/10.1016/j.juro.2014.02.2170

    Article  Google Scholar 

  17. Johnston M, Noureldin M, Abdelmotagly Y, Paramore L, Gehring T, Nedas T et al. (2020) Rezum water vapour therapy: promising early outcomes from the first UK series. BJU Int. https://doi.org/10.1111/bju.15203

    Article  PubMed  Google Scholar 

  18. Guelce D, Thomas D, Elterman D, Chughtai B. Recent advances in managing benign prostatic hyperplasia: the Rezūm System. F1000 Research. 2018;7(0):1916. https://f1000research.com/articles/7-1916/v1

  19. Yalcin S, Tunc L. Indications, techniques, and role of new minimally invasive benign prostate hyperplasia surgical options. Türk Üroloji Dergisi/Turkish J Urol. 2020; https://www.turkishjournalofurology.com/en/indications-techniques-and-role-of-new-minimally-invasive-benign-prostate-hyperplasia-surgical-options-133644

  20. S. Gravas , J.N. Cornu, M.J. Drake, M. Gacci CG, T.R.W. Herrmann, S. Madersbacher CM, Tikkinen KAO. EAU Guidelines Panel on Treatment of Non-neurogenic Male LUTS Guidelines: Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). Eur Assoc Urol. 2018; http://uroweb.org/wp-content/uploads/EAU-Guidelines-on-the-Management-of-Non-neurogenic-Male-LUTS-2018-large-text.pdf

  21. Roehrborn CG, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND et al. (2017) Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol. 197(6):1507–1516. https://doi.org/10.1016/j.juro.2016.12.045

    Article  PubMed  Google Scholar 

  22. Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Reports Urol. 2016; 8:207–16. https://www.dovepress.com/two-year-results-after-convective-radiofrequency-water-vapor-thermal-t-peer-reviewed-article-RRU

  23. Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA et al. (2017) Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Reports Urol 9:159–168

    Article  Google Scholar 

  24. Mollengarden D, Goldberg K, Wong D, Roehrborn C (2018) Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis. 21(3):379–385. https://doi.org/10.1038/s41391-017-0022-9

    Article  PubMed  Google Scholar 

  25. Bole R, Gopalakrishna A, Kuang R, Alamiri J, Yang DY, Helo S et al. (2020) Comparative postoperative outcomes of Rezūm prostate ablation in patients with large versus small glands. J Endourol 34(7):778–781

    Article  Google Scholar 

  26. Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM et al. (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 24(3):8802–8813

    PubMed  Google Scholar 

  27. Ulchaker JC, Martinson M. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Clin Outcomes Res. 2017; 10:29–43. https://www.dovepress.com/cost-effectiveness-analysis-of-six-therapies-for-the-treatment-of-lowe-peer-reviewed-article-CEOR

  28. Das AK, Leong JY, Roehrborn CG (2019) Office-based therapies for benign prostatic hyperplasia: a review and update. Can J Urol 26(4):2–7

    PubMed  Google Scholar 

  29. Otto B, Barbieri C, Lee R, Te AE, Kaplan SA, Robinson B, et al. Incidental Prostate Cancer in Transurethral Resection of the Prostate Specimens in the Modern Era. Adv Urol. 2014; 2014: 1–4. http://www.hindawi.com/journals/au/2014/627290/

  30. Abedi A, fallah karkan M, Allame F, Ranjbar A, Shadmehr A. Incidental prostate cancer: a 10-year review of a tertiary center, Tehran, Iran. Res Reports Urol. 2018 Jan; 10:1–6. https://www.dovepress.com/incidental-prostate-cancer-a-10-year-review-of-a-tertiary-center-tehra-peer-reviewed-article-RRU

  31. Rosario DJ, Phillips JT, Chapple CR (2007) Durability and Cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when α-adrenergic antagonist therapy fails. J Urol. 177(3):1047–1051. https://doi.org/10.1016/j.juro.2006.10.042

    Article  PubMed  Google Scholar 

  32. Mynderse LA, Roehrborn CG, Partin AW, Preminger GM, Coté EP (2011) Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol. 185(5):1804–1810. https://doi.org/10.1016/j.juro.2010.12.054

    Article  PubMed  Google Scholar 

  33. Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol. 50(5):969–980

    Article  Google Scholar 

  34. Alothman A, Alharbi R, Alasker A, Ghazwani Y. Sloughing Prostatic tissue, a rare complication post Rezum therapy: a case report. Cureus. 2020. https://www.cureus.com/articles/46407-sloughing-prostatic-tissue-a-rare-complication-post-rezum-therapy-a-case-report

Download references

Funding

We received no fund in our study.

Author information

Authors and Affiliations

  1. Ain Shams University Hospitals, Cairo, 11376, Egypt

    Ahmed Higazy & Tarek Osman

  2. Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Dana Osman

Authors
  1. Ahmed Higazy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana Osman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tarek Osman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed Higazy.

Ethics declarations

Conflict of interest

No competing interests to declare

Submission declaration

Our manuscript has not been published previously or under consideration for publication elsewhere, and its publication is approved by all authors in the current form, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Higazy, A., Osman, D. & Osman, T. Rezum: a novel minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A review article. Int Urol Nephrol 53, 1747–1756 (2021). https://doi.org/10.1007/s11255-021-02878-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-021-02878-8

Keywords

Search

Navigation